What is FDC Ltd (FDC) share price today?

FDC Ltd (FDC) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/FDC for the latest live price, technical analysis, and AI-powered insights.

How to analyse FDC stock?

VestAI provides comprehensive FDC stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is FDC Ltd in?

FDC Ltd (FDC) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

FDC Ltd

Name: FDC Ltd (FDC) Financial Metrics
Creator: VestAI

FDC

NSE· Healthcare

₹417.90

-2.20 (-0.52%)

Updated 12:21 pm IST

52W Low · ₹320.5052W High · ₹527.80

Mid Range

Market Cap

₹6203.06L Cr

Volume

74.1K

Prev Close

₹421.70

ISIN

INE258B01022

Orion Score

Fundamentals-based quality & risk · not a recommendation

68/100

Quality

FDC Ltd scores 68/100 (Quality) on the Orion Score — moderate business quality (68), moderate growth (59), strong balance-sheet safety (93) and fair valuation (48). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 0.8× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 4/9Altman Z Safe(10.96)Beneish M Elevated(-1.98)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

51/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.01x — lean balance sheet

QUALITY

Average

ROCE 11.2% — decent returns

MOMENTUM

Neutral

RSI 56.4 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 22.02
ROCE: 11.23%
ROE (1Y): 11.81%
D/E Ratio: 0.01x
OPM: 15.73%
TTM EPS: ₹17.30
Dividend Yield: 262.00%
Qtrly Sales: ₹584.79 Cr
Qtrly Profit: ₹103.40 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹584.79	₹103.4	15.7%	₹6.35
Q3 2026	₹464.71	₹28.3	8.1%	₹1.74
Q2 2026	₹473.03	₹28.37	3.9%	₹1.75
Q1 2026	₹648.41	₹121.35	19.4%	₹7.45
Q4 2025	₹491.89	₹38.67	7.8%	₹2.38

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹2,170.93	₹281.42	₹438.83	13.2%
FY 2025	₹2,108.12	₹266.79	₹415.46	12.9%
FY 2024	₹1,942.94	₹305.22	₹439.68	15.4%
FY 2023	₹1,777.83	₹194.04	₹300.31	11.9%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
FDC ★	₹6,203 Cr	22.02	11.23%	11.81%	0.01x	15.73%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹88,228 Cr	25.64	12.55%	9.93%	0.21x	15.11%
ASTERDMAster DM Quality	₹71,372 Cr	108.60	8.93%	10.07%	0.46x	13.98%
ABBOTINDIAAbbott India Limited	₹59,615 Cr	38.42	36.14%	34.46%	0.04x	27.01%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹2,713.8	₹2,468.09	₹2,342.94	₹2,270.2
Equity	₹2,281.08	₹2,097.17	₹1,982.05	₹1,956.79
Total Debt	₹21.17	₹20.52	₹28.32	₹32.2
Cash	₹51.47	₹25.42	₹23.89	₹37.73
Net Debt	—	—	—	—
Working Capital	₹727.08	₹755.87	₹715.35	₹728.03

Shareholding Pattern

Q1 FY2027

Promoter

69.95%

FII

4.11%

DII

3.37%

Public

22.57%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	69.95%	4.11% ↓	3.37%	22.57% ↑
Q4 FY2026	69.95% ↑	4.13% ↑	3.38% ↓	22.54% ↑
Q3 FY2026	69.66%	2.32% ↓	6.27% ↓	21.76% ↑
Q2 FY2026	69.66%	2.43% ↑	6.81% ↓	21.1% ↑
Q1 FY2026	69.66%	2.41% ↓	7.17% ↑	20.76% ↓
Q4 FY2025	69.66%	2.56% ↓	6.37% ↑	21.42% ↓
Q3 FY2025	69.66%	2.67% ↑	6.08% ↑	21.6% ↓
Q2 FY2025	69.66%	2.62%	6.02%	21.71%

Corporate Actions

Ex-Date	Action	Details
2026-02-11	DIVIDEND	Interim Dividend - Rs 5 Per Share

Funds Holding This Stock

12 mutual fund schemes

Tata India Pharma & Healthcare Fund Direct GrowthTATA

2.12%

₹29 Cr

ICICI Prudential ESG Exclusionary Strategy Fund Direct GrowthICICI_PRUDENTIAL

2.02%

₹27 Cr

Titanium Equity Long Short Fund Direct GrowthTITANIUM

1.46%

—

ICICI Prudential MNC Fund Direct GrowthICICI_PRUDENTIAL

1.13%

₹20 Cr

ICICI Prudential Smallcap Fund Direct Plan GrowthICICI_PRUDENTIAL

0.85%

₹76 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

0.77%

₹50 Cr

ICICI Prudential Retirement Fund Pure Equity Plan Direct GrowthICICI_PRUDENTIAL

0.49%

₹9 Cr

ICICI Prudential Bharat Consumption Fund Direct GrowthICICI_PRUDENTIAL

0.28%

₹9 Cr

Nippon India Small Cap Fund Direct GrowthRELIANCE

0.23%

₹172 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.13%

₹0 Cr

Analyse FDC with Orion AI

Ask: "Is FDC Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About FDC Ltd (FDC) Stock

FDC Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE258B01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.